СПОСОБ ПРОГНОЗИРОВАНИЯ РЕЦИДИВА РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ

摘要

FIELD: medicine, biochemical oncology. ^ SUBSTANCE: in the course of surveying in menopausal women after complex therapy one should state the development of mammary cancer at decreased ratio of estriol concentration to the sum of estrone and estradiol urinary concentrations from 1.68±0.23 in relapse-free patients up to 0.74±0.12 - in patients living without relapses for less than a year, up to 0.65±0.13 in patients living without relapse from 2 up to 6 years and up to 0.50±0.10 in patients with relapse-free period from 6 to 10 years. The innovation provides pre-clinical detection of mammary cancer relapse. ^ EFFECT: increased accuracy and simplicity of the technique applied. ^ 1 tbl